Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.
52 employees · est. 2015 · Waltham, United States
MiLaboratories
The next-gen software for biologics discovery
25 employees · est. 2021 · San Francisco, United States
Arrakis Therapeutics is the older company (2015 vs 2021); Arrakis Therapeutics is the larger of the two.
5 signals in the last 90 days
Side-by-Side Comparison
| Metric | Arrakis Therapeutics | MiLaboratories |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2021 |
| Headquarters | ||
| Headquarters | Waltham, United States | San Francisco, United States |
| Employees | ||
| Employees | 52 larger | 25 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Unknown | Seed |
| Total Funding | ||
| Total Funding | $115.00M | $2.36M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | RNA-targeted Small Molecule Development, Pipeline Management, Biotech Research and Development, Oral Medicines Development | VDJ Online Platform, Bioinformatics Tools, Software Licensing |
| Target Customers | ||
| Target Customers | Patients with Myotonic Dystrophy Type 1, Healthcare Providers, Biopharma Partners, Medical Researchers | Biomedical Researchers, Biotech Companies, Academic Institutions, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | RNA-targeted Therapies, Small-molecule Medicines, Drug Discovery, RNA Bioinformatics, RNA Structural Tools, Neurology, Oncology, Rare Genetic Diseases, RNA Biology, Pharmaceutical Innovation, Therapeutic Development, Medicinal Chemistry, Bioinformatics Integration | Not tracked yet |
| Website | ||
| Website | arrakistx.com | milaboratories.com |
About Arrakis Therapeutics
Arrakis Therapeutics is a pioneering player in the Biopharma and Biotechnology sector, headquartered in the United States. Founded in 2015, the company is on an ambitious mission to leverage RNA-targeted small molecule (rSM) therapies to revolutionize patient care. Their innovative approach adapts t...
About MiLaboratories
MiLaboratories has emerged as a key player in the Biotechnology sector with its leading software platform, MiXCR. Founded in 2021 and headquartered in the United States, the company is dedicated to enhancing immune repertoire profiling through the analysis of Next-Generation Sequencing (NGS) data....
We will tell you when either one moves
BounceWatch watches Arrakis Therapeutics and MiLaboratories for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Arrakis Therapeutics and MiLaboratories — by email.
Frequently Asked Questions
Compare Arrakis Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Arrakis Therapeutics on 15 Jun 2026, and MiLaboratories on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.